Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Modulation of Opioid Withdrawal in Opioid Use Disorder
NCT05729932Phase 1Recruiting
- Start
- Sep 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabis in opioid use disorder (OUD) (2 arms). Primary endpoint: Opioid Withdrawal Severity. Started Sep 2024; status: recruiting.
02
Drugs
cannabis
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05729932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729932.